Revision as of 11:57, 2 January 2020 editQuackGuru (talk | contribs)Extended confirmed users79,978 editsNo edit summary← Previous edit | Revision as of 13:45, 2 January 2020 edit undoQuackGuru (talk | contribs)Extended confirmed users79,978 editsNo edit summaryNext edit → | ||
Line 133: | Line 133: | ||
{{ping|Barkeep49}}, It might be worth clarifying in the ANI close whether updating and/or clarifying pricing information counts as adding and/or removing pricing. Looking at it one way, to change a price requires removing the old price and adding a new one, looking at it another way, the presence or absence of pricing remains constant. Clarifying the information is even more vaguely covered. Tagging for improvement does not appear to have been mentioned, and probably should remain that way as it is something likely to be done by totally uninvolved people. There remains the problem of what to do if another totally ininvolved person addresses a tag requesting improvement and makes an edit that could reasonably be considered an improvement, or just makes a plausible improvement. This is unlikely to happen often, so could possibly be simply ignored as mostly harmless. If the same person makes a habit of doing this, they could be notified of the dispute and embargo, but it would be preferable to disrupt normal encyclopedia-building activity as little as possible.· · · ] ]: 07:36, 2 January 2020 (UTC) | {{ping|Barkeep49}}, It might be worth clarifying in the ANI close whether updating and/or clarifying pricing information counts as adding and/or removing pricing. Looking at it one way, to change a price requires removing the old price and adding a new one, looking at it another way, the presence or absence of pricing remains constant. Clarifying the information is even more vaguely covered. Tagging for improvement does not appear to have been mentioned, and probably should remain that way as it is something likely to be done by totally uninvolved people. There remains the problem of what to do if another totally ininvolved person addresses a tag requesting improvement and makes an edit that could reasonably be considered an improvement, or just makes a plausible improvement. This is unlikely to happen often, so could possibly be simply ignored as mostly harmless. If the same person makes a habit of doing this, they could be notified of the dispute and embargo, but it would be preferable to disrupt normal encyclopedia-building activity as little as possible.· · · ] ]: 07:36, 2 January 2020 (UTC) | ||
Are editors aware of the ? This appears to be a violation of ]. ] (]) |
Are editors aware of the ? This appears to be a violation of ]. ] (]) 13:45, 2 January 2020 (UTC) | ||
== Reasons for including drug prices == | == Reasons for including drug prices == |
Revision as of 13:45, 2 January 2020
We have an offline version of our healthcare content. Download the app and access all this content when there's no Internet. (other languages) |
Translation Main page | Those Involved (sign up) | Newsletter |
Wrong Allegation!!Wrong Allegation On My Talk Page. https://en.wikipedia.org/User_talk:Jtb1917 I have not copied and pasted from the link given in your statement: "Is copied and pasted from http://apps.who.int/medicinedocs/en/d/Js4881e/5.2.html" I have used the latest list published by WHO, it's 21st list for making changes in the content. — Preceding unsigned comment added by Jtb1917 (talk • contribs) 13:53, 25 December 2019 (UTC) Please refer to Citation 3 in my last edit of the page. Link- https://en.wikipedia.org/search/?title=WHO_Model_List_of_Essential_Medicines&oldid=932301677 AS PER World Health Organization Model List of Essential Medicines (link-https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=1) "Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation:“This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.Suggested citation. World Health Organization Model Listof Essential Medicines, 21st List, 2019. Geneva: World Health Organization; 2019. Licence: CCBY-NC-SA3.0IGO." So, WHO as per its 21st list allows me to use content if I use the suggested reference. Thank You. Jtb1917 (talk) 13:40, 25 December 2019 (UTC)
HeadingThe entire literature of the last 15 years suggest that antibiotics treatment only should be favored as a first approach: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=appendectomy+vs+antibiotics&btnG=&oq=appendectomy+vs . If you estimate that the tone of this article doesn't currently reflect this fact, then modify it taking it into account. As currently the state of this article reflects beliefs that were held 20 years ago and is thus lacking important details to maintain relevance. — Preceding unsigned comment added by 178.197.228.43 (talk) 12:55, 26 December 2019 (UTC)
The Signpost: 27 December 2019
Silent strokes: Can CK-BB be used to diagnose?Let's say someone is in the hospital after a heart attack and they have CK Iso run and CK-BB comes back elevated w/o any other stroke symptoms. Wouldn't that suggest a Silent Stroke? Should CK Iso panel or CK-BB be added to methods of diagnosing silent strokes? https://en.wikipedia.org/Silent_stroke#Diagnosis Phantom in ca (talk) 18:09, 29 December 2019 (UTC)
A barnstar for you!
Happy New Year!Thanks for your contributions to Misplaced Pages, and a Happy New Year to you and yours! CAPTAIN RAJU 01:17, 31 December 2019 (UTC)
OscillococcinumFYI, there has been a recent uptick in the amount of inappropriate/non-neutral IP edits occurring on this page. It may warrant protection to allow editing only by non-IP users. TylerDurden8823 (talk) 06:53, 1 January 2020 (UTC)
Your recent edits to HydroxychloroquineHi Doc James. Happy New Year to you. In case you weren't aware, there's a comment here about how your recent edits to Hydroxychloroquine may have violated the ANI embargo on adding or removing drug pricing. --Ronz (talk) 17:02, 1 January 2020 (UTC) Hi James. As a reminder the ANI close remains in effect including
@Barkeep49:, It might be worth clarifying in the ANI close whether updating and/or clarifying pricing information counts as adding and/or removing pricing. Looking at it one way, to change a price requires removing the old price and adding a new one, looking at it another way, the presence or absence of pricing remains constant. Clarifying the information is even more vaguely covered. Tagging for improvement does not appear to have been mentioned, and probably should remain that way as it is something likely to be done by totally uninvolved people. There remains the problem of what to do if another totally ininvolved person addresses a tag requesting improvement and makes an edit that could reasonably be considered an improvement, or just makes a plausible improvement. This is unlikely to happen often, so could possibly be simply ignored as mostly harmless. If the same person makes a habit of doing this, they could be notified of the dispute and embargo, but it would be preferable to disrupt normal encyclopedia-building activity as little as possible.· · · Peter Southwood : 07:36, 2 January 2020 (UTC) Are editors aware of the list of most price edits since 2015 created by Colin? This appears to be a violation of WP:POLEMIC. QuackGuru (talk) 13:45, 2 January 2020 (UTC) Reasons for including drug pricesHi James, I am mot aware of the reasoning behind routinely including drug pricing in drug articles. I am getting the opposition reasoning explained in considerable detail, but that is one side of the debate. Is there a reasonably concise statement of the value of drug pricing as encyclopedic content, justifying its inclusion in all or most articles in a prominent position, somewhere that I can look it up for myself? Cheers, · · · Peter Southwood : 06:50, 2 January 2020 (UTC)
|